Evoke Pharma - 6 Year Stock Split History | EVOK

Stock split history for Evoke Pharma since 2013. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
Evoke Pharma Annual Stock Splits
Evoke Pharma Quarterly Stock Splits
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.013B $0.000B
Evoke Pharma, Inc. is a specialty pharmaceutical company focused primarily on the development of drugs to treat gastrointestinal disorders and diseases. The Company's lead product candidate, EVK-001, is in late stage clinical testing which is intended for the treatment of diabetic gastroparesis. Evoke Pharma, Inc. is based in San Diego, California.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $48.365B 8.71
Teva Pharmaceutical Industries (TEVA) Israel $14.938B 5.15
Mylan (MYL) United Kingdom $13.967B 5.91
Bausch Health Cos (BHC) Canada $8.440B 6.00
Dr Reddy's Laboratories (RDY) India $6.642B 26.49
Supernus Pharmaceuticals (SUPN) United States $1.980B 18.37
Mallinckrodt Public Limited Company (MNK) United Kingdom $1.809B 2.94
Amphastar Pharmaceuticals (AMPH) United States $0.963B 89.48
Homology Medicines (FIXX) United States $0.855B 0.00
CymaBay Therapeutics (CBAY) United States $0.746B 0.00
Voyager Therapeutics (VYGR) United States $0.666B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.423B 0.00
Assembly Biosciences (ASMB) United States $0.415B 0.00
Akorn (AKRX) United States $0.388B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.181B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.175B 0.00
Sol-Gel Technologies (SLGL) Israel $0.140B 0.00
Acasti Pharma (ACST) Canada $0.076B 0.00
Agile Therapeutics (AGRX) United States $0.064B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.062B 0.00
Teligent (TLGT) United States $0.046B 0.00
China Pharma Holdings (CPHI) China $0.016B 0.00
Aevi Genomic Medicine (GNMX) United States $0.015B 0.00